The safety of Mohs surgery: A prospective multicenter cohort study - 14/11/12
, Nicole Y. Lee, MD, MPH b, David G. Brodland, MD c, John A. Zitelli, MD c, Joel Cook, MD d
Correspondence to: Bradley G. Merritt, MD, Department of Dermatology, University of North Carolina at Chapel Hill, 410 Market Street, Suite 400, Chapel Hill, NC 27516.Abstract |
Background |
Complications associated with Mohs surgery have been evaluated by single-surgeon studies. While these studies provide evidence for the safety of the procedure, prospective, multicenter studies afford a higher level of clinical evidence and establish further the safety profile of Mohs surgery in the ambulatory setting.
Objective |
This study was designed to prospectively evaluate major and minor complications as well as postoperative pain associated with Mohs surgery.
Methods |
A multicenter prospective cohort study was conducted evaluating the rate of major and minor complications as well as postoperative pain associated with the treatment of skin cancer using Mohs surgery in 1550 patients with 1792 tumors. Follow-up was obtained in 1709 of the 1792 tumors treated (95.3%).
Results |
No major complications occurred during Mohs surgery or reconstruction. A total of 44 (2.6%) minor primary postoperative complications occurred during the study. On a scale from 0 to 10, the average peak postoperative pain level was 1.99.
Limitations |
Limitations of the study include the variability of practice patterns across practice sites as well as the 4.7% of patients lost to follow-up.
Conclusion |
Mohs surgery is performed with a high degree of safety and is well tolerated by patients.
Le texte complet de cet article est disponible en PDF.Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| Reprints not available from the authors. |
Vol 67 - N° 6
P. 1302-1309 - décembre 2012 Retour au numéro
Article précédent
- Net-like pattern of calcification on plain soft-tissue radiographs in patients with calciphylaxis
- Eugenia Shmidt, Naveen S. Murthy, John M. Knudsen, Roger H. Weenig, M. Amanda Jacobs, Autumn M. Starnes, Mark D.P. Davis
- D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk
- Agustí Toll, Javier Gimeno-Beltrán, Carla Ferrandiz-Pulido, Emili Masferrer, Mireia Yébenes, Anna Jucglà, Leandre Abal, Rosa M. Martí, Onofre Sanmartín, Teresa Baró, Beatriz Casado, Alberto Gandarillas, Carlos Barranco, Irmgard Costa, Sergi Mojal, Vicenç García-Patos, Ramon M. Pujol
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?